(1) Kolarsick PA, Kolarsick MA and Goodwin C. Anatomy and physiology of the skin. J. Dermatol. Nurses Assoc. (2011) 3: 203-13.
(2) Moura LI, Dias AM, Carvalho E and de Sousa HC. Recent advances on the development of wound dressings for diabetic foot ulcer treatment—a review. Acta Biomaterialia. (2013) 9: 7093-114.
(3) Berlanga Acosta J, Fernández Montequín J, Valdés Pérez C, Savigne Gutiérrez W, Mendoza Marí Y, García-Ojalvo A, Falcón Cama V, García del Barco Herrera D, Fernández Mayola M, Pérez Saad H, Pimentel Vázquez E, Urquiza Rodríguez A, Kulikovsky M and Guillén-Nieto G. Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome. BioMed. Res. Int. (2017) 2017: 1-10.
(4) McCarty SM and Percival SL. Proteases and Delayed Wound Healing. Adv. Wound Care (New Rochelle). (2013) 2: 438-47.
(5) Ayuk SM, Abrahamse H and Houreld NN. The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation. J. Diabetes Res. (2016) 2016: 1-9.
(6) Muller M, Trocme C, Lardy B, Morel F, Halimi S and Benhamou PY. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP‐1 to TIMP‐1 is a predictor of wound healing. Diabetic Med. (2008) 25: 419-26.
(7) Gill SE and Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. (2008) 40: 1334-47.
(8) Martins VL, Caley M and O'Toole EA. Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res. (2013) 351: 255-68.
(9) Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW and Liechty KW. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J. Invest. Dermatol. (2008) 128: 1852-60.
(10) Stearns ME, Rhim J and Wang M. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin. Cancer Res. (1999) 5: 189-96.
(11) Yao K, Li J, Yao F and Yin Y. Chitosan-based hydrogels: functions and applications, CRC Press2011.
(12) Ali A and Ahmed S. A review on chitosan and its nanocomposites in drug delivery. Int. J. Biol. Macromol. (2018) 109: 273-86.
(13) Dai T, Tanaka M, Huang YY and Hamblin MR. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert. Rev. Anti. Infect. Ther. (2011) 9: 857-79.
(14) Sarmento B and das Neves J. Chitosan-based systems for biopharmaceuticals: delivery, targeting and polymer therapeutics, John Wiley & Sons (2012).
(15) Minagawa T, Okamura Y, Shigemasa Y, Minami S and Okamoto Y. Effects of molecular weight and deacetylation degree of chitin/chitosan on wound healing. Carbohydr. Polym. (2007) 67: 640-44.
(16) Alsarra I A. Chitosan topical gel formulation in the management of burn wounds. Int. J. Biol. Macromol. (2009) 45: 16-21.
(17) Moeini A, Pedram P, Makvandi P, Malinconico M and Gomez d'Ayala G. Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings: A review. Carbohydr. Polym. (2020) 233: 115839.
(18) Baker MI, Walsh SP, Schwartz Z and Boyan BD. A review of polyvinyl alcohol and its uses in cartilage and orthopedic applications. J. Biomed. Mater. Res. B Appl. Biomater. (2012) 100: 1451-7.
(19) Shanmuganathan S, Shanumugasundaram N, Adhirajan N, Lakshmi TR and Babu M. Preparation and characterization of chitosan microspheres for doxycycline delivery. Carbohydr. Polym. (2008) 73: 201-11.
(20) Tort S, Acarturk F and Besikci A. Evaluation of three-layered doxycycline-collagen loaded nanofiber wound dressing. Int. J. Pharm. (2017) 529: 642-53.
(21) Sapadin A N and Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J. Am. Acad. Dermatol. (2006) 54: 258-65.
(22) Federici T J. The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease. Pharmacol. Res. (2011) 64: 614-23.
(23) Gu Y, Lee HM, Sorsa T, Salminen A, Ryan ME, Slepian MJ and Golub LM. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation. Pharmacol. Res. (2011) 64: 573-79.
(24) Tilakaratne A and Soory M. Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities. Open Dent. J. (2014) 8: 109-24.
(25) Zehtabi F, Ispas-Szabo P, Djerir D, Sivakumaran L, Annabi B, Soulez G, Mateescu M A and Lerouge S. Chitosan-doxycycline hydrogel: An MMP inhibitor/sclerosing embolizing agent as a new approach to endoleak prevention and treatment after endovascular aneurysm repair. Acta Biomater. (2017) 64: 94-105.
(26) Solomon A, Rosenblatt M, Li DQ, Liu Z, Monroy D, Ji Z, Lokeshwar BL and Pflugfelder SC. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest. Ophthalmol. Vis. Sci. (2000) 41: 2544-57.
(27) Bernardino AL, Kaushal D and Philipp MT. The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. J. Infect. Dis. (2009) 199: 1379-88.
(28) Jantzie LL and Todd KG. Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia–ischemia in neonatal rats. J. Psychiatry Neurosci. (2010) 35: 20-32.
(29) Chew SY, Wen Y, Dzenis Y and Leong KW. The role of electrospinning in the emerging field of nanomedicine. Curr. Pharm. Des. (2006) 12: 4751-70.
(30) Bhardwaj N and Kundu SC. Electrospinning: a fascinating fiber fabrication technique. Biotechnol. Adv. (2010) 28: 325-47.
(31) Hedayatyanfard K, Bagheri Khoulenjani S, Hashemi A and Ziai S A. Semi-IPN Films and Electrospun Nanofibers Based on Chitosan/PVA as an Antibacterial Wound Dressing. Iran. J. Pharm. Res. (2019) 18: 1156-67.
(32) Gundersen H, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard J, Pakkenberg B, Sørensen F B and Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Apmis (1988) 96: 379-94.
(33) Mühlfeld C, Nyengaard JR and Mayhew TM. A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovas Pathol. (2010) 19: 65-82.
(34) Velnar T, Bailey T and Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J. Int. Med. Res. (2009) 37: 1528-42.
(35) Guo S and Dipietro L A. Factors affecting wound healing. J. Dent. Res. (2010) 89: 219-29.
(36) Adhirajan N, Shanmugasundaram N, Shanmuganathan S and Babu M. Collagen-based wound dressing for doxycycline delivery: in-vivo evaluation in an infected excisional wound model in rats. J. Pharm. Pharmacol. (2009) 61: 1617-23.
(37) Moore AL, desJardins-Park HE, Duoto BA, Mascharak S, Murphy MP, Irizarry DM, Foster DS, Jones RE, Barnes LA, Marshall CD, Ransom RC, Wernig G and Longaker M T. Doxycycline Reduces Scar Thickness and Improves Collagen Architecture. Ann. Surg. (2020) 272: 183-93.
(38) Tian M, Qing C, Niu Y, Dong J, Cao X, Song F, Ji X and Lu S. Aminoguanidine cream ameliorates skin tissue microenvironment in diabetic rats. Arch. Med. Sci. (2016) 12: 179-87.
(39) Tian M, Qing C, Niu Y, Dong J, Cao X, Song F, Ji X and Lu S. Effect of aminoguanidine intervention on neutrophils in diabetes inflammatory cells wound healing. Exp. Clin. Endocrinol. Diabetes (2013) 121: 635-42.
(40) Tian M, Qing C, Niu Y, Dong J, Cao X, Song F, Ji X and Lu S. The relationship between inflammation and impaired wound healing in a diabetic rat burn model. J. Burn Care Res. (2016) 37: e115-e24.
(41) Lerman OZ, Galiano RD, Armour M, Levine J P and Gurtner G C. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am. J. Pathol. (2003) 162: 303-12.
(42) Okonkwo U A and DiPietro L A. Diabetes and Wound Angiogenesis, Int. J. Mol. Sci. (2017) 18: 1419.
(43) Mirza RE, Fang MM, Ennis WJ and Koh TJ. Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes (2013) 62: 2579-87.
(44) Han L, Su W, Huang J, Zhou J, Qiu S and Liang D. Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms. PLoS One (2014) 9: e108931.
(45) Valentín S, Morales A, Sánchez J L and Rivera A. Safety and efficacy of doxycycline in the treatment of rosacea. Clin. Cosmet. Investig. Dermatol. (2009) 2: 129-40.
(46) Castro JE, Vado Solis I, Perez Osorio C and Fredeking TM. Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever. Clin. Dev. Immunol. (2011) 2011: 370872.
(47) Xu F, Zhang C and Graves D T. Abnormal cell responses and role of TNF-in impaired diabetic wound healing. Biomed. Res. Int. (2013) 2013.
(48) Goren I, Müller E, Schiefelbein D, Christen U, Pfeilschifter J, Mühl H and Frank S. Systemic anti-TNFα treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J. Invest. Dermatol. (2007) 127: 2259-67.
(49) Di Caprio R, Lembo S, Di Costanzo L, Balato A and Monfrecola G. Anti-inflammatory properties of low and high doxycycline doses: an in-vitro study. Mediators. Inflamm. (2015) 2015: 329418.
(50) Sun J, Shigemi H, Tanaka Y, Yamauchi T, Ueda T and Iwasaki H. Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways. Biochem. Biophys. Reports. (2015) 4: 397-404.
(51) Mostafa Mtairag E, Chollet Martin S, Oudghiri M, Laquay N, Jacob MP, Michel JB and Feldman LJ. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secreti. Cardiovasc. Res. (2001) 49: 882-90.
(52) Silvestre JS, Mallat Z, Tamarat R, Duriez M, Tedgui A and Levy BI. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ. Res. (2001) 89: 259-64.
(53) Bostanci N, Akgul B, Tsakanika V, Allaker RP, Hughes FJ and McKay IJ. Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans. Cytokine (2011) 56: 656-61.
(54) Li Z, Guo S, Yao F, Zhang Y and Li T. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers, J. Diabetes Complications. (2013) 27: 380-2.
(55) Liu Y, Min D, Bolton T, Nubé V, Twigg S M, Yue D K and McLennan S V. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care (2009) 32: 117-19.
(56) Zhao S, Choksuchat C, Zhao Y, Ballagh SA, Kovalevsky GA and Archer DF. Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant. Contraception (2009) 79: 469-78.
(57) Gabriele S, Buchanan B, Kundu A, Dwyer HC, Gabriele J P, Mayer P and Baranowski DC. Stability, Activity, and Application of Topical Doxycycline Formulations in a Diabetic Wound Case Study. Wounds (2019) 31: 49-54.
(58) Choi DH, Moon IS, Choi BK, Paik JW, Kim YS, Choi SH and Kim CK. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J. Periodontal. Res. (2004) 39: 20-6.
(59) Qing C. The molecular biology in wound healing & non-healing wound. Chin. J. Traumatol. (2017) 20: 189-93.
(60) Serra R, Gallelli L, Buffone G, Molinari V, Stillitano D M, Palmieri C and de Franciscis S. Doxycycline speeds up healing of chronic venous ulcers. Int. Wound J. (2015) 12: 179-84.